Clinical Trial Results:
Estudio abierto, multicéntrico de acceso expandido de AMN107 oral en pacientes adultos con Imatinib (Glivec®/Gleevec®) para leucemia mieloide crónica intolerante o resistente en crisis blástica o fase acelerada o fase crónica
An open-label, multicenter, expanded access study of oral AMN 107 in adult patients with Imatinib (Glibec/Gleevec) -resistant or-intolerant chronic myeloid leukemia in blast crisis, accelerated phase or chronic phase
Summary
|
|
EudraCT number |
2005-001818-41 |
Trial protocol |
ES GB IE CZ SE DK BE HU AT DE PT GR SK IT |
Global completion date |
12 Nov 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Aug 2016
|
First version publication date |
28 Aug 2016
|
Other versions |
|
Summary report(s) |
CAMN107A2109.CTR.9Aug2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.